IVACARB Trademark

Trademark Overview

On Monday, May 11, 2015, a trademark application was filed for IVACARB with the United States Patent and Trademark Office. The USPTO has given the IVACARB trademark a serial number of 86625171. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 28, 2019. This trademark is owned by Lundbeck LLC. The IVACARB trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; diagnostic agents, preparations and substances for medical purposes
ivacarb

General Information

Serial Number86625171
Word MarkIVACARB
Filing DateMonday, May 11, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 28, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; diagnostic agents, preparations and substances for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 19, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLundbeck LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015
Party NameLundbeck LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, January 28, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 28, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, June 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 7, 2018EXTENSION 5 GRANTED
Wednesday, June 6, 2018EXTENSION 5 FILED
Wednesday, June 6, 2018TEAS EXTENSION RECEIVED
Friday, December 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2017EXTENSION 4 GRANTED
Wednesday, December 6, 2017EXTENSION 4 FILED
Wednesday, December 6, 2017TEAS EXTENSION RECEIVED
Tuesday, June 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 2, 2017EXTENSION 3 GRANTED
Friday, June 2, 2017EXTENSION 3 FILED
Friday, June 2, 2017TEAS EXTENSION RECEIVED
Tuesday, November 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 12, 2016EXTENSION 2 GRANTED
Tuesday, October 25, 2016EXTENSION 2 FILED
Thursday, November 10, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 25, 2016TEAS EXTENSION RECEIVED
Thursday, August 11, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 11, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2016EXTENSION 1 GRANTED
Thursday, April 21, 2016EXTENSION 1 FILED
Thursday, April 21, 2016TEAS EXTENSION RECEIVED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 21, 2015ASSIGNED TO LIE
Tuesday, August 25, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, August 25, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, August 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 21, 2015NON-FINAL ACTION E-MAILED
Friday, August 21, 2015NON-FINAL ACTION WRITTEN
Friday, August 21, 2015ASSIGNED TO EXAMINER
Tuesday, May 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 14, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

ivacarb preparations substances pharmaceutical disorder disease central system treatment prevention nervous